A lot of people are concerned about cancer drugs these days, and we've planned to introduce some knowledge about this kind of life-saving drugs. So the duration of today's "Service for this Week" will be a bit long. After all, medical treatment requires a little patience.

Through negotiations earlier in 2017, 15 anti-cancer drugs such as Herceptin, Rituximab, and Bortezomib with great efficacy but high price were included in the National Drug Reimbursement List (NDRL).

The following article will make you know more about generic drugs ↓

Why do we encourage generics? What about their efficacy? This article covers the contents related to health-care and medicine

Since April of this year, the China's National Drug Administration (CNDA) has accelerated the approval of seven new overseas drugs urgently needed for the prevention and treatment of serious life-threatening diseases. These drugs included nine-valent human papillomavirus vaccine, Sofosbuvir and Velpatasvir tablets for Hepatitis C, Ninlaro capsules for multiple myeloma, Ceritinib capsules for non-small cell lung cancer, Lucentis injection for impairment of vision caused by macular oedema, Nivolumab injection for locally advanced or metastatic non-small cell lung cancer, and Emicizumab injection for rare diseases.